• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者中的耐药光滑念珠菌感染。

Drug-resistant Candida glabrata infection in cancer patients.

作者信息

Farmakiotis Dimitrios, Tarrand Jeffrey J, Kontoyiannis Dimitrios P

出版信息

Emerg Infect Dis. 2014 Nov;20(11):1833-40. doi: 10.3201/eid2011.140685.

DOI:10.3201/eid2011.140685
PMID:25340258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4214312/
Abstract

Cancer patients are at risk for candidemia, and increasing Candida spp. resistance poses an emerging threat. We determined rates of antifungal drug resistance, identified factors associated with resistance, and investigated the correlation between resistance and all-cause mortality rates among cancer patients with ≥1 C. glabrata-positive blood culture at MD Anderson Cancer Center, Houston, Texas, USA, during March 2005-September 2013. Of 146 isolates, 30 (20.5%) were resistant to fluconazole, 15 (10.3%) to caspofungin, and 10 (6.8%) to multiple drugs (9 caspofungin-resistant isolates were also resistant to fluconazole, 1 to amphotericin B). Independently associated with fluconazole resistance were azole preexposure, hematologic malignancy, and mechanical ventilation. Independently associated with caspofungin resistance were echinocandin preexposure, monocytopenia, and total parenteral nutrition. Fluconazole resistance was highly associated with caspofungin resistance, independent of prior azole or echinocandin use. Caspofungin resistance was associated with increased 28-day all-cause mortality rates. These findings highlight the need for good stewardship of antifungal drugs.

摘要

癌症患者有发生念珠菌血症的风险,念珠菌属耐药性不断增加构成了新的威胁。我们在美国得克萨斯州休斯敦市MD安德森癌症中心,对2005年3月至2013年9月期间血培养光滑念珠菌阳性≥1次的癌症患者,测定了抗真菌药物耐药率,确定了与耐药相关的因素,并研究了耐药与全因死亡率之间的相关性。在146株分离株中,30株(20.5%)对氟康唑耐药,15株(10.3%)对卡泊芬净耐药,10株(6.8%)对多种药物耐药(9株对卡泊芬净耐药的分离株也对氟康唑耐药,1株对两性霉素B耐药)。与氟康唑耐药独立相关的因素有唑类药物预先暴露、血液系统恶性肿瘤和机械通气。与卡泊芬净耐药独立相关的因素有棘白菌素预先暴露、单核细胞减少和全胃肠外营养。氟康唑耐药与卡泊芬净耐药高度相关,与先前使用唑类或棘白菌素无关。卡泊芬净耐药与28天全因死亡率增加相关。这些发现凸显了对抗真菌药物进行良好管理的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc1/4214312/371eaff626d2/14-0685-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc1/4214312/371eaff626d2/14-0685-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cc1/4214312/371eaff626d2/14-0685-F.jpg

相似文献

1
Drug-resistant Candida glabrata infection in cancer patients.癌症患者中的耐药光滑念珠菌感染。
Emerg Infect Dis. 2014 Nov;20(11):1833-40. doi: 10.3201/eid2011.140685.
2
Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.科威特临床光滑念珠菌分离株中抗真菌药物敏感性、棘白菌素类耐药的分子基础以及氟康唑耐药的分子流行病学。
Sci Rep. 2020 Apr 10;10(1):6238. doi: 10.1038/s41598-020-63240-z.
3
Increasing Trends of Reduced Susceptibility to Antifungal Drugs Among Clinical Isolates in Kuwait.科威特临床分离株对抗真菌药物敏感性降低的趋势增加。
Microb Drug Resist. 2020 Aug;26(8):982-990. doi: 10.1089/mdr.2019.0437. Epub 2020 Feb 26.
4
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.光滑念珠菌中唑类抗真菌药物交叉耐药的临床意义
J Clin Microbiol. 2006 May;44(5):1740-3. doi: 10.1128/JCM.44.5.1740-1743.2006.
5
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
6
Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin.来自伊朗的光滑念珠菌临床分离株的药敏谱及对卡泊芬净的遗传耐药机制。
Rev Iberoam Micol. 2018 Apr-Jun;35(2):88-91. doi: 10.1016/j.riam.2018.01.002.
7
Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.FKS突变在光滑念珠菌中的作用:最低抑菌浓度值、棘白菌素耐药性和多重耐药性。
Antimicrob Agents Chemother. 2014 Aug;58(8):4690-6. doi: 10.1128/AAC.03255-14. Epub 2014 Jun 2.
8
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.氟康唑耐药近平滑念珠菌血流分离株对棘白菌素类药物敏感性降低和耐药性的频率。
J Clin Microbiol. 2012 Apr;50(4):1199-203. doi: 10.1128/JCM.06112-11. Epub 2012 Jan 25.
9
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.棘白菌素类耐药性在光滑念珠菌中的增加:临床失败与 FKS 突变和最低抑菌浓度升高相关。
Clin Infect Dis. 2013 Jun;56(12):1724-32. doi: 10.1093/cid/cit136. Epub 2013 Mar 13.
10
Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.棘白菌素 MIC 与既往棘白菌素暴露的光滑念珠菌侵袭性念珠菌病患者的治疗结局相关。
Antimicrob Agents Chemother. 2013 Aug;57(8):3528-35. doi: 10.1128/AAC.00136-13. Epub 2013 May 13.

引用本文的文献

1
Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China.中国广东省临床光滑念珠菌分离株中棘白菌素耐药性的流行情况及分子基础
BMC Microbiol. 2025 Aug 20;25(1):521. doi: 10.1186/s12866-025-04275-y.
2
Azole resistance: patterns of amino acid substitutions in Candida sterol 14α-demethylase.唑类抗性:白色念珠菌固醇14α-去甲基酶中的氨基酸取代模式
Antonie Van Leeuwenhoek. 2025 Apr 17;118(5):68. doi: 10.1007/s10482-025-02080-1.
3
Emergence of invasive candidiasis with multiple species exhibiting azole and echinocandin resistance.

本文引用的文献

1
Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.FKS突变在光滑念珠菌中的作用:最低抑菌浓度值、棘白菌素耐药性和多重耐药性。
Antimicrob Agents Chemother. 2014 Aug;58(8):4690-6. doi: 10.1128/AAC.03255-14. Epub 2014 Jun 2.
2
FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.FKS 突变的光滑念珠菌:菌血症患者的危险因素和结局。
Clin Infect Dis. 2014 Sep 15;59(6):819-25. doi: 10.1093/cid/ciu407. Epub 2014 May 30.
3
In vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection.
出现侵袭性念珠菌病,多种念珠菌对唑类和棘白菌素耐药。
Front Microbiol. 2025 Mar 25;16:1550894. doi: 10.3389/fmicb.2025.1550894. eCollection 2025.
4
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways.超越传统抗真菌药物:通过新型治疗途径对抗耐药性。
Pharmaceuticals (Basel). 2025 Mar 4;18(3):364. doi: 10.3390/ph18030364.
5
Antifungal effect of atorvastatin in comparison with fluconazole on species isolated from patients undergoing head-and-neck radiotherapy.阿托伐他汀与氟康唑对从接受头颈放疗患者中分离出的菌种的抗真菌作用比较
Dent Res J (Isfahan). 2024 Dec 20;21:68. doi: 10.4103/drj.drj_550_23. eCollection 2024.
6
Nosocomial transmission of fluconazole-resistant bloodstream isolates revealed by whole-genome sequencing.全基因组测序揭示耐氟康唑血流分离株的医院内传播。
Microbiol Spectr. 2024 Oct 3;12(10):e0088324. doi: 10.1128/spectrum.00883-24. Epub 2024 Aug 20.
7
Antifungal Resistance Mechanisms and Associated Epidemiology.抗真菌耐药机制及相关流行病学
J Fungi (Basel). 2023 Jul 28;9(8):798. doi: 10.3390/jof9080798.
8
Whole-Genome Sequence Analysis of Isolates from a Patient with Persistent Fungemia and Determination of the Molecular Mechanisms of Multidrug Resistance.对一名持续性真菌血症患者的分离菌株进行全基因组序列分析并确定多重耐药的分子机制
J Fungi (Basel). 2023 Apr 26;9(5):515. doi: 10.3390/jof9050515.
9
Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features.含棘白菌素的皮肤念珠菌病凝胶制剂:氮酮和肉豆蔻酸异丙酯对生物药剂学特性的影响
Gels. 2023 Apr 6;9(4):308. doi: 10.3390/gels9040308.
10
Multiple genome analysis of clinical isolates renders new insights into genetic diversity and drug resistance determinants.临床分离株的多基因组分析为遗传多样性和耐药性决定因素提供了新见解。
Microb Cell. 2022 Oct 13;9(11):174-189. doi: 10.15698/mic2022.11.786. eCollection 2022 Nov 7.
光滑念珠菌对卡泊芬净的体外抗真菌药敏性以及FKS基因突变的存在与侵袭性感染免疫受损小鼠模型中的治疗反应相关。
Antimicrob Agents Chemother. 2014 Jul;58(7):3646-9. doi: 10.1128/AAC.02666-13. Epub 2014 Apr 14.
4
Impact of new antifungal breakpoints on antifungal resistance in Candida species.新型抗真菌药物折点对念珠菌属抗真菌药物耐药性的影响。
J Clin Microbiol. 2014 Mar;52(3):994-7. doi: 10.1128/JCM.03044-13. Epub 2014 Jan 8.
5
Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.在一项对常规进行血流分离株药敏试验的医院进行的多中心研究中,棘白菌素对念珠菌属的最低抑菌浓度(MIC)的真实世界经验。
Antimicrob Agents Chemother. 2014;58(4):1897-906. doi: 10.1128/AAC.02163-13. Epub 2014 Jan 6.
6
Candida glabrata: a review of its features and resistance.光滑念珠菌:特征及其耐药性综述。
Eur J Clin Microbiol Infect Dis. 2014 May;33(5):673-88. doi: 10.1007/s10096-013-2009-3. Epub 2013 Nov 19.
7
Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.美国念珠菌属引起的医院血流感染:菌种分布、临床特征和抗真菌药敏性。
Int J Antimicrob Agents. 2014 Jan;43(1):78-81. doi: 10.1016/j.ijantimicag.2013.09.005. Epub 2013 Oct 12.
8
Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance.阿尼芬净和米卡芬净的 MIC 折点优于卡泊芬净,可用于鉴定 FKS 突变的光滑念珠菌菌株和棘白菌素耐药性。
Antimicrob Agents Chemother. 2013 Dec;57(12):6361-5. doi: 10.1128/AAC.01451-13. Epub 2013 Sep 23.
9
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?使用CLSI和EUCAST方法检测念珠菌属对卡泊芬净的最低抑菌浓度(MIC)的实验室间变异性:临床实验室是否应该检测这种药物?
Antimicrob Agents Chemother. 2013 Dec;57(12):5836-42. doi: 10.1128/AAC.01519-13. Epub 2013 Sep 9.
10
Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case-control study.外周和全肠外营养是老年患者医院内念珠菌血症的最强危险因素:一项匹配病例对照研究。
Mycoses. 2013 Nov;56(6):664-71. doi: 10.1111/myc.12090. Epub 2013 May 16.